Literature DB >> 15253323

Racial differences in analgesic/anti-inflammatory medication use and perceptions of efficacy.

Kelli L Dominick1, Hayden B Bosworth, Jason B Hsieh, Barry K Moser.   

Abstract

BACKGROUND AND
OBJECTIVE: Pharmacotherapy is a key component to osteoarthritis (OA) treatment. Research has shown important racial differences in pain thresholds and perceptions, but little is known about racial variations in responses to pain medications. The purpose of this study was to compare perceptions of efficacy of pain medications among African-American and Caucasian veterans with OA.
METHODS: Participants (N = 202; 70% Caucasian, 30% African-American) were under care for OA within the VA healthcare system. Participants rated the helpfulness of current analgesic/anti-inflammatory medications (scale of 1--not at all helpful to 10--very helpful).
RESULTS: The mean rating of medication helpfulness was 6.1. African-American participants reported significantly greater ratings of medication helpfulness than Caucasians (6.6 vs. 5.9), controlling for demographics, disease severity, total number of analgesic/anti-inflammatory medications being taken, and the class of the medication.
CONCLUSION: African Americans had somewhat more favorable perceptions of medication helpfulness than Caucasians. However, overall ratings of medication helpfulness were relatively low. Further research is needed to examine whether modifiable factors (such as low dosing or patient nonadherence to prescription instructions) contribute to perceptions of poor efficacy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15253323      PMCID: PMC2568439     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  20 in total

1.  Variation in perceptions of treatment and self-care practices in elderly with osteoarthritis: a comparison between African American and white patients.

Authors:  S A Ibrahim; L A Siminoff; C J Burant; C K Kwoh
Journal:  Arthritis Rheum       Date:  2001-08

2.  Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey.

Authors:  Barbara Mintzes; Morris L Barer; Richard L Kravitz; Arminée Kazanjian; Ken Bassett; Joel Lexchin; Robert G Evans; Richard Pan; Stephen A Marion
Journal:  BMJ       Date:  2002-02-02

3.  Prevalence of disabilities and associated health conditions among adults--United States, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-02-23       Impact factor: 17.586

4.  The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties.

Authors:  S McConnell; P Kolopack; A M Davis
Journal:  Arthritis Rheum       Date:  2001-10

5.  Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States.

Authors:  R C Lawrence; C G Helmick; F C Arnett; R A Deyo; D T Felson; E H Giannini; S P Heyse; R Hirsch; M C Hochberg; G G Hunder; M H Liang; S R Pillemer; V D Steen; F Wolfe
Journal:  Arthritis Rheum       Date:  1998-05

6.  A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib/Ibuprofen Comparator Study Group.

Authors:  R Day; B Morrison; A Luza; O Castaneda; A Strusberg; M Nahir; K B Helgetveit; B Kress; B Daniels; J Bolognese; D Krupa; B Seidenberg; E Ehrich
Journal:  Arch Intern Med       Date:  2000-06-26

7.  Ethnic differences in pain tolerance: clinical implications in a chronic pain population.

Authors:  R R Edwards; D M Doleys; R B Fillingim; D Lowery
Journal:  Psychosom Med       Date:  2001 Mar-Apr       Impact factor: 4.312

8.  Prevalence of self-reported arthritis or chronic joint symptoms among adults--United States, 2001.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-10-25       Impact factor: 17.586

9.  Rofecoxib shows consistent efficacy in osteoarthritis clinical trials, regardless of specific patient demographic and disease factors.

Authors:  L M Detora; D Krupa; J Bolognese; R S Sperling; E W Ehrich
Journal:  J Rheumatol       Date:  2001-11       Impact factor: 4.666

Review 10.  The increasing impact of arthritis on public health.

Authors:  M J Elders
Journal:  J Rheumatol Suppl       Date:  2000-10
View more
  10 in total

1.  Ethnic Group Differences in the Outcomes of Multidisciplinary Pain Treatment.

Authors:  Brian Merry; Claudia M Campbell; Luis F Buenaver; Lynanne McGuire; Jennifer A Haythornthwaite; Daniel M Doleys; Robert R Edwards
Journal:  J Musculoskelet Pain       Date:  2011-01

Review 2.  Racial and ethnic differences in the experience and treatment of noncancer pain.

Authors:  Samantha M Meints; Alejandro Cortes; Calia A Morais; Robert R Edwards
Journal:  Pain Manag       Date:  2019-05-29

3.  Older black adult osteoarthritis pain communication.

Authors:  Denise Puia; Deborah Dillon McDonald
Journal:  Pain Manag Nurs       Date:  2012-11-06       Impact factor: 1.929

Review 4.  Racial-Ethnic Differences in Osteoarthritis Pain and Disability: A Meta-Analysis.

Authors:  Ivana A Vaughn; Ellen L Terry; Emily J Bartley; Nancy Schaefer; Roger B Fillingim
Journal:  J Pain       Date:  2018-12-10       Impact factor: 5.820

Review 5.  Racial and ethnic differences in the pharmacologic management of osteoarthritis: rapid systematic review.

Authors:  Ernest R Vina; Philip H Tsoukas; Shahrzad Abdollahi; Nidhi Mody; Stephanie C Roth; Albert H Redford; C Kent Kwoh
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-06-30       Impact factor: 3.625

6.  What race and ethnicity measure in pharmacologic research.

Authors:  Jamie Mihoko Doyle
Journal:  J Clin Pharmacol       Date:  2006-04       Impact factor: 3.126

Review 7.  Racial and ethnic disparities in the VA health care system: a systematic review.

Authors:  Somnath Saha; Michele Freeman; Joahd Toure; Kimberly M Tippens; Christine Weeks; Said Ibrahim
Journal:  J Gen Intern Med       Date:  2008-02-27       Impact factor: 5.128

8.  A randomized study of the efficacy and safety of parecoxib for the treatment of pain following total knee arthroplasty in Korean patients.

Authors:  Margaret Noyes Essex; Hee-Youn Choi; Pritha Bhadra Brown; Raymond Cheung
Journal:  J Pain Res       Date:  2018-02-23       Impact factor: 3.133

9.  Clinic variation in recruitment metrics, patient characteristics and treatment use in a randomized clinical trial of osteoarthritis management.

Authors:  Kelli D Allen; Hayden B Bosworth; Ranee Chatterjee; Cynthia J Coffman; Leonor Corsino; Amy S Jeffreys; Eugene Z Oddone; Catherine Stanwyck; William S Yancy; Rowena J Dolor
Journal:  BMC Musculoskelet Disord       Date:  2014-12-06       Impact factor: 2.362

10.  Quantifying Mediators of Racial Disparities in Knee Osteoarthritis Outcome Scores: A Cross-Sectional Analysis.

Authors:  Jennifer Simkin; John Valentino; Wentao Cao; Christina McCarthy; Jonathan Schuon; Jacob Davis; Luis Marrero; Vinod Dasa; Claudia Leonardi; Qingzhao Yu
Journal:  JB JS Open Access       Date:  2021-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.